Literature DB >> 34381169

Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.

Asmita Mishra1, Joseph Pidala2, Ram Thapa3, Brian C Betts4, Hugo Fernandez5, Frederick L Locke2, Taiga Nishihori2, Lia Perez2, Xuefeng Wang3, Claudio Anasetti2, Heather Jim6.   

Abstract

We conducted a prospective study of adult allogeneic hematopoietic cell transplantation (HCT) recipients to assess pre- and post-HCT physical function. Baseline measurements included a wrist actigraphy, a 6 min walk test (6MWT), an international physical activity questionnaire (IPAQ), and a Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) as well as serial post-HCT assessments of 6MWT, IPAQ, and FACT-BMT. Forty-seven patients were evaluable for functionality assessments, with a median follow-up of 54.5 months for surviving recipients. No patients demonstrated vigorous or very vigorous activity at any time during monitoring by wrist actigraphy; patients spent a median of 6 h daily sedentary. Self-reported activity via the IPAQ showed 36%, 43%, and 21% of subjects reporting light, moderate, and vigorous activity prior to HCT, respectively. Post-HCT 6MWTs on day +30 demonstrated the greatest association with subsequent survival and non-relapse mortality. A decline in 6MWT distance over time also demonstrated worsened overall survival. This study shows the feasibility of fitness assessments and the ability to risk stratify for subsequent mortality, particularly using the 6MWT on the day +30 single time point assessment and change scores from baseline to day +30 post HCT. These pilot findings suggest important targets for future study.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34381169     DOI: 10.1038/s41409-021-01428-1

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  24 in total

1.  Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.

Authors:  M F Bevans; S Marden; N K Leidy; K Soeken; G Cusack; P Rivera; H Mayberry; M R Bishop; R Childs; A J Barrett
Journal:  Bone Marrow Transplant       Date:  2006-06-05       Impact factor: 5.483

2.  ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-09-27       Impact factor: 29.690

3.  2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliot L Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

4.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

5.  Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).

Authors:  William A Wood; Jennifer Le-Rademacher; Karen L Syrjala; Heather Jim; Paul B Jacobsen; Jennifer M Knight; Muneer H Abidi; John R Wingard; Navneet S Majhail; Nancy L Geller; J Douglas Rizzo; Mingwei Fei; Juan Wu; Mary M Horowitz; Stephanie J Lee
Journal:  Cancer       Date:  2015-10-06       Impact factor: 6.860

6.  Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.

Authors:  Eileen Hacker Danaher; Carol Ferrans; Ellen Verlen; Farhad Ravandi; Koen van Besien; Julie Gelms; Natalie Dieterle
Journal:  Oncol Nurs Forum       Date:  2006-05-03       Impact factor: 2.172

7.  Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study.

Authors:  W A Wood; A M Deal; B B Reeve; A P Abernethy; E Basch; S A Mitchell; C Shatten; Y Hie Kim; J Whitley; J S Serody; T Shea; C Battaglini
Journal:  Bone Marrow Transplant       Date:  2013-04-15       Impact factor: 5.483

8.  Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.

Authors:  Mohamed L Sorror; Barry E Storer; David G Maloney; Brenda M Sandmaier; Paul J Martin; Rainer Storb
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

9.  Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.

Authors:  Karen L Syrjala; Shelby L Langer; Janet R Abrams; Barry Storer; Jean E Sanders; Mary E D Flowers; Paul J Martin
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

10.  Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.

Authors:  Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Pulsipher; Peter A McSweeney; Rainer Storb
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

View more
  2 in total

1.  Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.

Authors:  Li-Wen Huang; Ying Sheng; Charalambos Andreadis; Aaron C Logan; Gabriel N Mannis; Catherine C Smith; Karin M L Gaensler; Thomas G Martin; Lloyd E Damon; Chiung-Yu Huang; Rebecca L Olin
Journal:  Transplant Cell Ther       Date:  2022-03-03

Review 2.  Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy.

Authors:  Obada Obaisi; Rhodora C Fontillas; Krina Patel; An Ngo-Huang
Journal:  Curr Oncol Rep       Date:  2022-03-10       Impact factor: 5.945

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.